Skip to main content

Want a detailed portfolio tracker?

Relmada Therapeutics (RLMD) Revenue (2012 - 2026)

Relmada Therapeutics (RLMD) revenue from Feb 29, 2012 to Mar 31, 2026. The TTM Relmada Therapeutics (RLMD) revenue is $0. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Quarterly Revenue

Annual Revenue change of Relmada Therapeutics (RLMD)

YearRevenueChange
2026$0N/A
2025$0N/A
2024$0N/A
2023$0N/A
2022$0N/A
2021$0N/A
2020$0N/A
2019$0N/A
2018$0N/A
2017$0N/A
2016$0N/A
2015$0N/A
2014$0N/A
2013$0-100.00%
2012$10KN/A